Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
47.15
-2.49 (-5.02%)
Apr 1, 2025, 4:00 PM EDT - Market closed

Disc Medicine Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-109.36-76.43-46.83-35.97-20.94
Depreciation & Amortization
0.160.10.090.030.02
Loss (Gain) From Sale of Investments
-5.3----
Stock-Based Compensation
16.825.532.090.510.12
Other Operating Activities
0.530.290.276.610.32
Change in Accounts Payable
-4.68-3.740.531.32-0.51
Change in Other Net Operating Assets
7.910.791.6-0.031.01
Operating Cash Flow
-93.93-73.46-42.25-27.53-19.97
Capital Expenditures
-0.51-0.09-0.15-0.07-0.08
Investment in Securities
-291.83----
Investing Cash Flow
-292.33-0.09-0.15-0.07-0.08
Long-Term Debt Issued
28.99----
Net Debt Issued (Repaid)
28.99----
Issuance of Common Stock
190.72201.8151.120.070
Other Financing Activities
-1.3937.58-2.14--
Financing Cash Flow
218.31239.38148.9889.9334.98
Net Cash Flow
-167.94165.83106.5862.3314.94
Free Cash Flow
-94.43-73.55-42.4-27.6-20.04
Free Cash Flow Per Share
-3.42-3.30-40.79-31.42-2.89
Cash Interest Paid
0.2----
Cash Income Tax Paid
0.30.11---
Levered Free Cash Flow
-61.01-54.31-19.91-10.87-
Unlevered Free Cash Flow
-60.65-54.31-19.91-10.87-
Change in Net Working Capital
-3.962.9-7.73-8-
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q